BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22222887)

  • 1. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression.
    Peterson RA
    Toxicol Pathol; 2012; 40(2):186-204. PubMed ID: 22222887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
    Yurchenko E; Levings MK; Piccirillo CA
    Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
    Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
    Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
    Roncarolo MG; Gregori S; Levings M
    Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulatory T cells].
    Marinić I; Gagro A; Rabatić S
    Acta Med Croatica; 2006 Dec; 60(5):447-56. PubMed ID: 17217101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
    Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
    J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
    Lo Re S; Lecocq M; Uwambayinema F; Yakoub Y; Delos M; Demoulin JB; Lucas S; Sparwasser T; Renauld JC; Lison D; Huaux F
    Am J Respir Crit Care Med; 2011 Dec; 184(11):1270-81. PubMed ID: 21868503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
    Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
    Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
    Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
    Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.
    Lahl K; Loddenkemper C; Drouin C; Freyer J; Arnason J; Eberl G; Hamann A; Wagner H; Huehn J; Sparwasser T
    J Exp Med; 2007 Jan; 204(1):57-63. PubMed ID: 17200412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic regulatory T cells.
    Maggi E; Cosmi L; Liotta F; Romagnani P; Romagnani S; Annunziato F
    Autoimmun Rev; 2005 Nov; 4(8):579-86. PubMed ID: 16214099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
    Bedke T; Pretsch L; Karakhanova S; Enk AH; Mahnke K
    J Immunol; 2010 May; 184(10):5562-70. PubMed ID: 20382886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.